- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07475221
Ekspertvalidering av en autonom personlig tilpasset fysisk aktivitetsalgoritme (APPA e-Delphi)
Validering av en personalisert fysisk aktivitetsalgoritme via modifisert e-Delphi (InnovaMotion-prosjektet)
This study aims to validate a personalized physical activity algorithm for risk screening and individualized exercise prescription using a modified online Delphi process. International experts in physical activity and exercise will evaluate the algorithm's components over two rounds of questionnaires, with consensus defined as ≥70% agreement. If needed, a focus group will resolve any remaining disagreements. Validation of this algorithm may support safer, more effective autonomous exercise, promoting adherence, improved health outcomes, and population-level benefits.
Studieoversikt
Status
Detaljert beskrivelse
Study Phases - eDelphi Validation of the APPA Algorithm
Phase 1 - Round 1 (Initial Online Questionnaire):
The first phase consists of an online survey in which international experts in physical activity and exercise will evaluate the components of the personalized physical activity algorithm for health risk screening and individualized exercise prescription. Experts will assess the relevance, clarity, and clinical appropriateness of each item. Feedback from this round will identify items requiring modification or clarification.
Phase 2 - Round 2 (Re-evaluation):
The second phase consists of a consecutive online survey round, in which experts will re-evaluate the revised algorithm components based on feedback from Round 1. Experts will have the opportunity to adjust their ratings. This phase aims to move items closer to consensus (≥70% agreement).
Phase 3 - Optional Focus Group (if needed):
If consensus is not reached on specific items after Round 2, an online focus group will be conducted to discuss and resolve remaining disagreements. This discussion will help refine the algorithm and ensure agreement on all components.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiesteder
-
-
-
Porto, Portugal, 4200-072
- School of Health - Polytechnic Institute of Porto
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The study population will consist of international experts in the field of Physical Activity and Exercise. Participants will be identified based on their recognized scientific or professional experience and possession of a relevant doctoral degree. Recruitment will be primarily via institutional email invitations, supplemented by personal contacts when needed. Eligible experts will voluntarily participate in two rounds of an online modified Delphi questionnaire and, if required, an online focus group to resolve any remaining disagreements. The targeted panel size is 9 - 18 experts to ensure representativeness and methodological robustness.
Beskrivelse
Inclusion Criteria
- Experts in Physical Activity and Exercise with recognized scientific or professional experience and a relevant doctoral degree.
- Availability to complete two rounds of the online modified Delphi questionnaire.
- Willingness to participate in an online focus group if consensus is not reached.
- Ability and willingness to provide informed consent.
Exclusion Criteria
- Individuals unable to provide informed consent.
- Individuals without access to a computer, smartphone, tablet, or other internet-enabled device necessary to complete the online survey.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Expert Panel
Cohort of experts in physical activity and exercise with recognized scientific or professional experience and a relevant doctoral degree. Experts will validate a digital algorithm for health risk screening and individualized physical activity prescription via a modified online Delphi process. Two rounds of anonymous questionnaires will assess the relevance, clarity, and clinical appropriateness of algorithm components. If consensus (≥70% agreement) is not reached, a follow-up online focus group will resolve disagreements. Recruitment will be through institutional emails and professional networks. Participation is voluntary, with informed consent obtained. Panel size: 9-18 experts, consistent with Delphi methodology to ensure representativeness and robustness. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Expert consensus on algorithm components
Tidsramme: Up to 2 months
|
Consensus defined as ≥70% agreement among experts using a 9-point Likert scale in a two-round modified Delphi process evaluating the relevance and clarity of algorithm items. |
Up to 2 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studieleder: Andreia SP Sousa, Center for Rehabilitation Research
- Studieleder: António M Montes, Center for Rehabilitation Research
- Studieleder: Anabela C Martins, H&TR-Health & Technology Research Center, Coimbra Health School, Polytechnic University of Coimbra
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CE0073F
- 02/C06-i03.03/2021.PID-15 (Annet stipend/finansieringsnummer: InnovHealth Scholarships, funded by the Impulso Jovens STEAM Programme within the Resilient P.PORTO Programme)
- UID/05210/2025 (Annet stipend/finansieringsnummer: Fundação para a Ciência e Tecnologia (FCT))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .